You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ezetimibe

Showing 1 - 25 of 112
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypercholesterolemia Trial (Inclisiran, Ezetimibe, Matching Placebo for Inclisiran)

Not yet recruiting
  • Hypercholesterolemia
  • (no location specified)
Feb 28, 2023

Metabolic Syndrome Trial in Houston (Simvastatin, Vytorin, Placebo)

Completed
  • Metabolic Syndrome
  • Houston, Texas
    Baylor College of Medicine
Jul 21, 2022

Hypercholesterolemia Trial (Atorvastatin, Ezetimibe, Ezetimibe/atorvastatin)

Completed
Has Results
  • Hypercholesterolemia
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia Trial (Atorvastatin, Ezetimibe, Ezetimibe/atorvastatin)

Completed
Has Results
  • Hypercholesterolemia
  • (no location specified)
Feb 7, 2022

Primary Hypercholesterolemia Trial (Ezetimibe, Atorvastatin, Rosuvastatin)

Completed
Has Results
  • Primary Hypercholesterolemia
  • Ezetimibe
  • +2 more
  • (no location specified)
Feb 7, 2022

Cholesterol Trial (ezetimibe, Comparator: Placebo (unspecified), simvastatin)

Completed
  • Cholesterol
  • ezetimibe
  • +2 more
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia Trial (Ezetimibe, atorvastatin)

Completed
Has Results
  • Hypercholesterolemia
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia Trial (Ezetimibe, Simvastatin)

Completed
Has Results
  • Hypercholesterolemia
  • (no location specified)
Feb 7, 2022

Ezetimibe onSelect Population of Filipinos With

Completed
Has Results
  • Primary Hypercholesterolemia
  • Homozygous Familial Hypercholesterolemia
  • Ezetimibe
  • (no location specified)
Feb 7, 2022

Cholesterol Trial (ezetimibe, Comparator: cyclosporine)

Completed
  • Cholesterol
  • ezetimibe
  • Comparator: cyclosporine
  • (no location specified)
Feb 7, 2022

Inclisiran on Major Adverse Cardiovascular Events in French

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • Inclisiran sodium
  • +3 more
  • (no location specified)
Jul 26, 2023

Hypercholesterolemia Trial (ezetimibe, statins)

Completed
  • Hypercholesterolemia
  • (no location specified)
Feb 7, 2022

Hyperlipidemia Trial (Ezetimibe, Ezetimibe/atorvastatin 10mg/10mg FDC, Atorvastatin 10mg)

Completed
  • Hyperlipidemia
  • Ezetimibe
  • +4 more
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia, Coronary Heart Disease Trial (ezetimibe, )

Completed
  • Hypercholesterolemia
  • Coronary Heart Disease
  • ezetimibe
  • placebo
  • (no location specified)
Feb 7, 2022

Ezetimibe Achieved in Co-administration Therapy With Statins

Completed
Has Results
  • Hypercholesterolemia
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia, Coronary Arteriosclerosis Trial (Ezetimibe, Placebo, Atorvastatin 10 mg)

Completed
Has Results
  • Hypercholesterolemia
  • Coronary Arteriosclerosis
  • Ezetimibe
  • +2 more
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia Trial (ezetimibe, simvastatin, Placebo (Unspecified))

Completed
  • Hypercholesterolemia
  • ezetimibe
  • +2 more
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia, Atherosclerosis Trial (Ezetimibe, Placebo)

Terminated
  • Hypercholesterolemia
  • Atherosclerosis
  • Ezetimibe
  • Placebo
  • (no location specified)
Feb 7, 2022

Low-density Lipoprotein Cholesterol Levels in Coronary Heart

Completed
Has Results
  • Hypercholesterolemia
  • Ezetimibe
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia, Familial Hypercholesterolemia Trial (Ezetimibe, Rosuvastatin)

Completed
Has Results
  • Hypercholesterolemia
  • Familial Hypercholesterolemia
  • (no location specified)
Feb 7, 2022

Cardiovascular Disorder Trial (Ezetimibe, simvastatin)

Completed
  • Cardiovascular Disorder
  • (no location specified)
Feb 7, 2022

A 52-week Post-marketing, Observational Study to Confirm Safety

Completed
  • Hypercholesterolemia
  • +2 more
  • Ezetimibe
  • Ezetimibe + other lipid-lowering medication(s)
  • (no location specified)
Feb 7, 2022

A 12-week Post-marketing, Observational Study to Confirm Safety

Completed
  • Hypercholesterolemia
  • +2 more
  • Ezetimibe
  • Ezetimibe + other lipid-lowering medication(s)
  • (no location specified)
Feb 7, 2022

Primary Hypercholesterolemia, Mixed Dyslipidemias Trial in Australia, New Zealand, Taiwan (Pitavastatin, Ezetimibe, 1PC111)

Completed
  • Primary Hypercholesterolemia
  • Mixed Dyslipidemias
  • Blacktown, Australia
  • +33 more
May 17, 2022

Russian Coronary Heart Disease <<Treat to Goal>> (Study P05464)

Completed
Has Results
  • Coronary Heart Disease
  • Hypercholesterolemia
  • (no location specified)
Feb 7, 2022